$23.35
2.22%
NYSE, Sep 18, 04:01 pm EDT. Closed.

CryoLife Target price 2026 - Analyst rating & recommendation

CryoLife Classifications & Recommendation

Buy
93%
Hold
7%

CryoLife Price Target

Target Price $42.84
Price $23.35
Potential
Number of Estimates 10
10 Analysts have issued a price target CryoLife 2027 . The average CryoLife target price is $42.84. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 13 Analysts recommend CryoLife to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CryoLife stock has an average upside potential 2027 of . Most analysts recommend the CryoLife stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 441.33 500.18
13.59% 13.33%
EBITDA Margin 9.35% 19.43%
37.31% 107.78%
Net Margin 2.21% -3.48%
164.41% 257.36%

10 Analysts have issued a sales forecast CryoLife 2026 . The average CryoLife sales estimate is

$500m
unlock
. This is
6.09% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$520m 10.24%
unlock
, the lowest is
$470m 0.23%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $441m 13.59%
2026
$500m 13.33%
unlock
2027
$554m 10.77%
unlock
2028
$620m 11.89%
unlock
2029
$691m 11.54%
unlock
2030
$779m 12.69%
unlock

9 Analysts have issued an CryoLife EBITDA forecast 2026. The average CryoLife EBITDA estimate is

$97.2m
unlock
. This is
238.10% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$104m 260.44%
unlock
, the lowest is
$90.2m 213.71%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $41.3m 28.80%
2026
$97.2m 135.45%
unlock
2027
$117m 20.44%
unlock
2028
$141m 20.51%
unlock
2029
$178m 26.50%
unlock
2030
$211m 18.12%
unlock

EBITDA Margin

2025 9.35% 37.31%
2026
19.43% 107.78%
unlock
2027
21.12% 8.70%
unlock
2028
22.75% 7.72%
unlock
2029
25.80% 13.41%
unlock
2030
27.05% 4.84%
unlock

10 CryoLife Analysts have issued a net profit forecast 2026. The average CryoLife net profit estimate is

$-17.4m
unlock
. This is
450.00% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-8.2m 158.86%
unlock
, the lowest is
$-30.5m 866.46%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $9.8m 173.16%
2026
$-17.4m 278.07%
unlock
2027
$14.3m 182.51%
unlock
2028
$23.0m 60.18%
unlock
2029
$90.9m 295.65%
unlock
2030
$116m 27.33%
unlock

Net Margin

2025 2.21% 164.41%
2026
-3.48% 257.36%
unlock
2027
2.59% 174.43%
unlock
2028
3.71% 43.24%
unlock
2029
13.14% 254.18%
unlock
2030
14.85% 13.01%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 0.21 -0.36
165.63% 271.43%
P/E negative
EV/Sales 2.86

10 Analysts have issued a CryoLife forecast for earnings per share. The average CryoLife EPS is

$-0.36
unlock
. This is
414.29% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.17 142.86%
unlock
, the lowest is
$-0.63 800.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $0.21 165.63%
2026
$-0.36 271.43%
unlock
2027
$0.29 180.56%
unlock
2028
$0.47 62.07%
unlock
2029
$1.87 297.87%
unlock
2030
$2.38 27.27%
unlock

P/E ratio

Current -333.57 219.64%
2026
-65.41 80.39%
unlock
2027
79.28 221.20%
unlock
2028
49.50 37.56%
unlock
2029
12.51 74.73%
unlock
2030
9.82 21.50%
unlock

Based on analysts' sales estimates for 2026, the CryoLife stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.03 41.17%
2026
2.86 5.76%
unlock
2027
2.58 9.72%
unlock
2028
2.30 10.63%
unlock
2029
2.07 10.35%
unlock
2030
1.83 11.26%
unlock

P/S ratio

Current 2.41 49.07%
2026
2.28 5.74%
unlock
2027
2.05 9.72%
unlock
2028
1.84 10.63%
unlock
2029
1.65 10.34%
unlock
2030
1.46 11.26%
unlock

Current CryoLife Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
Locked
Locked Aug 18 2026
Needham
Locked
Locked
Locked Jul 20 2026
Canaccord Genuity
Locked
Locked
Locked Jun 16 2026
Citizens
Locked
Locked
Locked May 08 2026
Needham
Locked
Locked
Locked May 08 2026
Ladenburg Thalmann
Locked
Locked
Locked Apr 10 2026
Needham
Locked
Locked
Locked Apr 07 2026
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
Locked
Aug 18 2026
Locked
Needham:
Locked
Locked
Jul 20 2026
Locked
Canaccord Genuity:
Locked
Locked
Jun 16 2026
Locked
Citizens:
Locked
Locked
May 08 2026
Locked
Needham:
Locked
Locked
May 08 2026
Locked
Ladenburg Thalmann:
Locked
Locked
Apr 10 2026
Locked
Needham:
Locked
Locked
Apr 07 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today